Skip to main content
. 2016 Aug;13(8):701–711. doi: 10.11909/j.issn.1671-5411.2016.08.009

Figure 2. FGF23 (A-C) and FGF21 (D-F) immuno-staining.

Figure 2.

(A): All control cardiomyocytes show moderate staining; (B): FGF23 staining increases intensely in cardiomyocytes from HCVR patients; (C): relative values of optical density according to groups; (D): the staining in cardiomyocytes from control patients is faint; (E): the staining increased in cells from HCVR patients; and (F): relative values of optical density according to groups. Original magnification 100 ×; scale bar = 20 µm; **P < 0.01. HCVR: higher cardiovascular risk; IOD: integrated optical density.